Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema. Huber KL, Stino H, Steiner I, Fuchs P, et al. Invest Ophthalmol Vis Sci 2024;65:46.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Huber KL, Stino H, Steiner I, Fuchs P, et al. Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema. Invest Ophthalmol Vis Sci 2024;65:46.
PMID: 39739347